Jun 23, 2026
17 MIN READ

Why Does Ozempic Make You Constipated? Understanding the Connection

Semaglutide slows stomach emptying to reduce appetite, but this mechanism can lead to constipation in many patients. Understanding the connection helps you manage this side effect effectively.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 23, 2026
17 MIN READ

why does ozempic make you constipated? understanding the connection — PlexusDx GLP-1 education

Last reviewed: June 24, 2026

Last updated: June 24, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works by mimicking glucagon-like peptide-1, a hormone that signals fullness to your brain and slows how quickly food moves through your digestive system. While this mechanism drives weight loss, it can also cause constipation—one of the most frequently reported side effects during the first weeks of treatment. Knowing why this happens and how to address it helps you stay comfortable on your medication.

How Semaglutide Slows Your Digestive System

Semaglutide activates GLP-1 receptors throughout your gastrointestinal tract, triggering a cascade of signals that tell your stomach to empty more slowly. This delayed gastric emptying is intentional—it keeps you feeling satisfied longer and reduces overall food intake. However, this same slowdown affects your entire digestive system, including your colon, where water reabsorption and stool movement become sluggish.

Clinical trials show that GLP-1 receptor agonists reduce gut motility by approximately 20–30% in the first month of treatment. This means food spends more time in your digestive tract, allowing your body to absorb more water from stool and making bowel movements harder and less frequent. The effect is most pronounced during dose escalation, when your body is still adjusting to the medication.

Dehydration compounds the problem. When semaglutide reduces your appetite, you naturally eat less—and often drink less fluid as well. Without adequate water intake, your colon reabsorbs even more moisture from stool, creating a perfect environment for constipation. This is why hydration is one of the first interventions recommended by prescribing clinicians.

Why Constipation Hits Harder in the First Weeks

Your digestive system doesn't immediately adapt to semaglutide. In the first 2–4 weeks of treatment, your gut muscles are learning to respond to a hormone level much higher than your body produces naturally. During this adjustment window, constipation rates can reach 20–30% in clinical populations. Most patients experience mild to moderate symptoms, though severe cases do occur and warrant discussion with your prescriber.

Dose escalation intensifies this effect. PlexusDx semaglutide injections begin at lower doses and increase gradually over weeks, allowing your system to adapt. Patients who move too quickly through dose escalation or who start at higher doses often report worse constipation. Conversely, those who follow a measured titration schedule frequently report that side effects improve as their body develops tolerance.

Interestingly, constipation often peaks around weeks 3–6 and then improves substantially by week 8–12, even without medication changes. This suggests your gut develops adaptive mechanisms that partially counteract the medication's slowing effect. However, you shouldn't wait passively for relief—proactive management from day one prevents discomfort and improves treatment adherence.

Practical Strategies to Prevent and Relieve Constipation

Increase water intake before you feel thirsty. Aim for at least 80–100 ounces daily, more if you exercise or live in a warm climate. Many semaglutide patients find that setting phone reminders and keeping a water bottle visible helps maintain consistent hydration. Herbal teas, broths, and sugar-free beverages count toward your fluid goal. Avoid caffeine and alcohol in excess, as both can dehydrate you further.

Add soluble fiber gradually to your diet through sources like oatmeal, ground flaxseed, chia seeds, and low-glycemic vegetables. The key word is gradually—jumping to high fiber intake all at once can actually worsen constipation temporarily as your gut adjusts. Aim to increase fiber by 5 grams per week until you reach 25–30 grams daily. Pair every increase with extra water.

Move your body regularly. Even 15–20 minutes of walking after meals stimulates intestinal contractions and promotes bowel regularity. Gentle yoga, stretching, and abdominal massage (moving clockwise around your abdomen) can also help. Physical activity benefits weight loss independent of medication and addresses constipation without pharmaceutical intervention.

When Constipation Signals a Need to Adjust Your Treatment

Severe constipation—defined as no bowel movement for more than 3 days, accompanied by abdominal pain, bloating, or nausea—requires immediate contact with your prescriber. In rare cases, semaglutide can contribute to bowel obstruction or impaction, especially in patients with a history of gastrointestinal disease. Your clinician may recommend temporarily pausing dose escalation, reducing your current dose, or switching to a different GLP-1 formulation to find the right balance between efficacy and tolerability.

PlexusDx offers both injection and oral semaglutide options, as well as microdose and dual-compound protocols that may work better for your individual system. The Precision Peptide Genetic Test identifies how your body metabolizes peptide hormones through variants in genes like GLP1R (rs6923761), which influence your baseline sensitivity to GLP-1 receptor activation. Patients with certain GLP1R variants sometimes experience more pronounced side effects at standard doses, and genetic insights can guide your prescriber toward a more personalized dose titration schedule.

The Bottom Line: Constipation Is Manageable

Constipation on semaglutide is a physiological consequence of how the medication works, not a sign of failure or reason to stop treatment. Most cases resolve within 8–12 weeks as your body adapts, and proactive hydration, fiber, and movement address symptoms effectively in the interim. Managing this side effect well ensures you can stay on a medication that works for your weight loss goals without unnecessary discomfort.

If you're considering semaglutide or currently experiencing constipation, connect with your PlexusDx prescriber to discuss your individual risk factors and personalization options. Compounded semaglutide from licensed 503A pharmacies starts at $149/month with no insurance required, and the Precision Peptide Genetic Test ($99 add-on after your first month) can reveal whether genetic factors are making you more sensitive to GLP-1 effects. The right dose, formulation, and support strategy puts you in control of your side effects and your results.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is constipation a sign that semaglutide isn't right for me?

No. Constipation is an expected, manageable side effect that occurs because semaglutide slows your digestive system to reduce appetite. It typically improves within 8–12 weeks as your body adapts. Hydration, fiber, and movement address it in the short term. If constipation is severe or doesn't improve, your prescriber can adjust your dose or explore alternative GLP-1 formulations through PlexusDx.

How common is constipation with semaglutide treatment?

Clinical trials show constipation affects 20–30% of patients during the first weeks of treatment, making it one of the more frequent early side effects. Rates often decline after week 8 as the gut adapts. Severe constipation is less common and warrants prescriber discussion.

Can I take a laxative while on semaglutide?

Yes, osmotic laxatives like magnesium citrate and polyethylene glycol (Miralax) are safe and effective with semaglutide. Start with the gentlest option—increased water and fiber—and add a laxative only if needed. Avoid stimulant laxatives long-term unless directed by your clinician. Always inform your prescriber about any new medications.

Does the genetic test predict whether I'll get constipated?

The PlexusDx Precision Peptide Genetic Test identifies variants in GLP1R (rs6923761) and other genes that influence how sensitively your body responds to GLP-1 activation. Certain variants correlate with stronger receptor activity and may increase the likelihood of GLP-1 side effects, including constipation. These insights help your prescriber personalize your dose escalation to minimize discomfort.

What's the difference between injectable and oral semaglutide for constipation risk?

Both forms activate GLP-1 receptors and can cause constipation, but some patients tolerate one better than the other. PlexusDx compounded semaglutide injection starts at $149/month and oral semaglutide at $249/month. Your prescriber can help determine which formulation, dose schedule, or alternative GLP-1 (like tirzepatide or microdose protocols) suits your body's needs.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves